Bioage Labs Inc (BIOA)
Bioage Labs stock today
Bioage Labs closed at $5.87 on October 30, 2026, down 1.18% on the day. Over the past year it returned -24.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $261 million.
| Period | BIOA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -17.2% | -0.9% |
| 3 months | -76.4% | +2.1% |
| Year to date | -55.6% | +11.7% |
| 1 year | -24.1% | +12.4% |
Key statistics
- Market value
- $261M
- Price / sales
- 25.2
- 52-week range
- $4.84 to $25.10
- Next report
- Nov 5, 2026 (estimated)
About Bioage Labs
Develops therapeutics and diagnostics focused on aging-related diseases and longevity.
Sector: Health Care
More on Bioage Labs
- Returns: what $1,000 became$1,000 one year ago is $759.38 today
No forecast, no recommendation. This page describes Bioage Labs Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.